Utama › Penyakit Autoimun › Iowa
Kajian klinikal Penyakit Autoimun di Iowa
7 kajian untuk Penyakit Autoimun sedang mencari peserta di lokasi di Iowa.
Bandar di Iowa
Teks kajian rasmi (Bahasa Inggeris)
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06722235A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
Mengambil pesertaFasa 1
Umur 18 hingga 74 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- The University of Iowa, Iowa City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- University of Iowa Hospitals and Clinics, Iowa City
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06858319A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Iowa, Iowa City
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06056297A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Iowa, Iowa City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- University of Iowa, Iowa City
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Mei 2026 · NCT04422912Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.